150 unknown. 150 Phase 1, 65 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 150 | Unknown 150 |
| Phase 2 | 65 | Unknown 65 |
Follow Pneumonia: new trials by email Literature Review of Pneumonia trials Research Report on Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia TP-122A - Pneumonia, Ventilator-Associated | Phase 1 / Phase 2 | Unknown | Technophage, SA | 15 | 2024-09-01 | 2024-04-17 |
| Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure intravenous treatment with EVs, intravenous treatment with placebo solution - Severe Acute Respiratory Syndrome (SARS), Acute Respiratory Distress Syndrome (ARDS) | Phase 1 / Phase 2 | Unknown | D'Or Institute for Research and Education | 15 | 2024-02-01 | 2023-08-21 |
| Stem Cell Study for Long COVID-19 Neurological Symptoms Stem Cell - Post-Acute COVID-19 Syndrome | Phase 1 | Unknown | Charles Cox | 12 | 2024-01-01 | 2023-12-05 |
| Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS). VIX001 - Post-Acute COVID-19 Syndrome, Cognitive Impairment | Phase 1 | Unknown | Neobiosis, LLC | 9 | 2023-10-01 | 2023-07-17 |
| The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19 MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8), MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8), MSC-exosomes delivered intravenously every other day (8:8:8) - Covid19, Novel Coronavirus Pneumonia | Phase 1 / Phase 2 | Unknown | AVEM HealthCare | 55 | 2023-09-01 | 2022-03-11 |
| Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients umbilical cord mesenchymal stem cell - Long COVID, Post-Acute COVID-19 Syndrome | Phase 1 / Phase 2 | Unknown | Changhai Hospital | 76 | 2023-09-01 | 2024-07-09 |
| Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo - COVID-19 | Phase 1 | Unknown | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 100 | 2023-09-01 | 2023-09-25 |
| Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection Adipose Tissue Harvest, ATCell - Long COVID | Phase 1 | Unknown | American CryoStem Corporation | 20 | 2023-08-01 | 2023-06-09 |
| A Study to Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults TI-0010, Placebo - COVID-19, COVID-19 Immunisation | Phase 1 | Unknown | National Drug Clinical Trial Institute of the Second Affiliated Hospital of Bengbu Medical College | 100 | 2023-07-10 | 2024-01-18 |
| SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19 SA55 Injection, Placebo for SA55 injection - COVID-19 | Phase 1 | Unknown | Sinovac Life Sciences Co., Ltd. | 40 | 2023-06-15 | 2023-09-22 |
| Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation - COVID-19 | Phase 1 | Unknown | Wuhan BravoVax Co., Ltd. | 60 | 2023-06-01 | 2023-04-25 |
| SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People SA55 nasal spray - COVID-19 | Phase 1 | Unknown | Sinovac Life Sciences Co., Ltd. | 80 | 2023-05-31 | 2023-09-21 |
| COVID-19 Vaccination Detoxification in LDL-C Atorvastatin Calcium Tablets - COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction | Phase 1 | Unknown | Yang I. Pachankis | 1 | 2023-05-01 | 2023-05-06 |
| Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults Glycovax-002 - SARS-CoV-2 | Phase 1 | Unknown | Glycovax Pharma Inc. | 36 | 2023-04-28 | 2024-09-24 |
| A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10 μg - SARS-CoV-2 Infection | Phase 1 | Unknown | CNBG-Virogin Biotech (Shanghai) Ltd. | 164 | 2023-03-10 | 2023-11-08 |
| A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine MVX01, MVX01 Placebo - Pneumococcal Vaccine | Phase 1 | Unknown | Matrivax Research and Development Corporation | 75 | 2023-03-07 | 2024-03-29 |
| A Randomized Controlled Trial of a Digital, Self-testing Strategy for COVID-19 Infection in South Africa. Abbott Panbio rapid antigen self-tests, COVIDSmart CARE! app - COVID-19 | Phase 1 / Phase 2 | Unknown | McGill University Health Centre/Research Institute of the McGill University Health Centre | 600 | 2023-02-02 | 2023-10-23 |
| Study of HS-10517 in Chinese Adult Participants HS-10517 Dose 1, HS-10517 Dose 2, HS-10517 Dose 3 - COVID-19 | Phase 1 / Phase 2 | Unknown | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 340 | 2023-02-01 | 2023-04-03 |
| Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection Umbilical cord mesenchymal stem cells implantation, Comparator - COVID-19 | Phase 1 / Phase 2 | Unknown | Hebei Medical University | 20 | 2023-01-28 | 2023-02-23 |
| A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19 RQ3013, Comirnaty - COVID-19 | Phase 1 | Unknown | Walvax Biotechnology Co., Ltd. | 120 | 2022-12-01 | 2022-11-18 |
Showing 20 of 150. Sign in to see all of them.
COVID-19 (136) · Coronavirus Infections (14) · Respiratory Distress Syndrome (7) · Post-Acute COVID-19 Syndrome (5) · Severe Acute Respiratory Syndrome (4) · Cognitive Dysfunction (3) · Pneumonia, Viral (3) · Pulmonary Fibrosis (3) · Inflammation (2) · Neoplasms (2) · Pneumococcal Infections (2) · Pneumonia, Pneumococcal (2) · Pneumonia, Ventilator-Associated (2) · Acute Kidney Injury (1)
Lung Diseases (150) · Respiratory Tract Diseases (150) · Infections (149) · Respiratory Tract Infections (149) · Coronaviridae Infections (141) · Nidovirales Infections (141) · RNA Virus Infections (141) · Virus Diseases (141) · Pneumonia, Viral (138) · Coronavirus Infections (127) · Pathological Conditions, Signs and Symptoms (21) · Pathologic Processes (20) · Disease Attributes (13) · Respiration Disorders (8)
Saline Solution (6) · BNT162 Vaccine (4) · Injections (3) · Standard of Care (3) · Acetylcysteine (2) · COVID-19 Vaccines (2) · RQ3013 COVID-19 vaccine (2) · SCTV01C vaccine (2) · Sodium Chloride (2) · remdesivir (2) · tocilizumab (2) · 13-valent pneumococcal vaccine (1) · 2019-nCoV Vaccine mRNA-1273 (1) · 3,6-di-O-acetyl-2-deoxy-D-glucopyranose (1) · AV-COVID-19 vaccine (1)
D'Or Institute for Research and Education (3) · Shanghai Zerun Biotechnology Co.,Ltd (3) · The University of Hong Kong (3) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (2) · Beijing 302 Hospital (2) · Cairo University (2) · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (2) · GeneOne Life Science, Inc. (2) · Hadassah Medical Organization (2) · Hospital Reg. Lic. Adolfo Lopez Mateos (2) · Hospital de Clinicas de Porto Alegre (2) · Kafrelsheikh University (2) · Shahid Beheshti University of Medical Sciences (2) · Sinocelltech Ltd. (2) · Sinovac Life Sciences Co., Ltd. (2)
China (32) · United States (15) · Brazil (9) · Mexico (6) · Egypt (5) · Israel (5) · Indonesia (4) · Iran (4) · United Arab Emirates (4) · Hong Kong (3) · Pakistan (3) · South Korea (3) · Turkey (Türkiye) (3) · United Kingdom (3) · Austria (2)
Ivan Fan-ngai Hung (2) · Lanjuan Li (2) · Lin Yuan (2) · Lucia Silla, MD, PhD (2) · Moneeb Ashraf, MBBS (2) · Muhammad Ashraf, PhD (2) · Shoaib Ashraf, PhD (2) · Sohaib Ashraf, MBBS (2) · Yang Wang, Ph.D. (2) · Ahmad Ameri, Prof. (1) · Albert G Frauman, MD (1) · Aldar Bourinbayar, MD/PhD (1) · Alejandro Alanis-Vega, MD (1) · Amir Kiani, PhD (1)
PMID 34473343, PMID 31986264, PMID 32257537, PMID 10051178, PMID 10415784, PMID 10669330, PMID 11023960, PMID 11886437, PMID 12563677, PMID 1406879, PMID 14719037, PMID 15663512, PMID 16787239, PMID 17181919, PMID 18097874, PMID 18369153, PMID 18552864, PMID 19397687, PMID 19453649, PMID 19998041, PMID 20370679, PMID 21131395, PMID 22028728, PMID 22187937, PMID 22545014, PMID 22731679, PMID 25076907, PMID 25291189, PMID 25329189, PMID 25457751, PMID 26867177, PMID 27856631, PMID 28583206, PMID 28584818, PMID 29619244, PMID 29719970, PMID 29859173, PMID 30473697, PMID 31978293, PMID 31986257, PMID 32007143, PMID 32035018, PMID 32071063, PMID 32085846, PMID 32089354, PMID 32109013, PMID 32112977, PMID 32113509, PMID 32122636, PMID 32125452